comparemela.com

Latest Breaking News On - Johnl marshall - Page 4 : comparemela.com

Innovations Needed in GI Cancer and Key Takeaways from ESMO 2023

LEAP-017: Lenvatinib and Pembrolizumab in MSS mCRC

The LEAP-017 trial results presented at ESMO GI 2023 are explored by Dr Marshall.

Development Challenges in Microsatellite Stable mCRC

Dr Marshall discusses challenges associated with microsatellite stable metastatic colorectal cancer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.